207 related articles for article (PubMed ID: 15913574)
1. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
[TBL] [Abstract][Full Text] [Related]
2. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
3. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Järbe TU; DiPatrizio NV
Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal delta9-tetrahydrocannabinol exposure.
Suárez I; Bodega G; Fernández-Ruiz J; Ramos JA; Rubio M; Fernández B
Cerebellum; 2004; 3(2):66-74. PubMed ID: 15233572
[TBL] [Abstract][Full Text] [Related]
5. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain.
Porcella A; Gessa GL; Pani L
Eur J Neurosci; 1998 May; 10(5):1743-51. PubMed ID: 9751146
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.
Zhuang S; Kittler J; Grigorenko EV; Kirby MT; Sim LJ; Hampson RE; Childers SR; Deadwyler SA
Brain Res Mol Brain Res; 1998 Nov; 62(2):141-9. PubMed ID: 9813289
[TBL] [Abstract][Full Text] [Related]
7. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
8. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
Dhawan K; Kumar S; Sharma A
J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
10. Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats.
Braida D; Iosuè S; Pegorini S; Sala M
Eur J Pharmacol; 2004 Dec; 506(1):63-9. PubMed ID: 15588625
[TBL] [Abstract][Full Text] [Related]
11. SR 141716A differentially attenuates the behavioral effects of delta9-THC in rhesus monkeys.
McMahon LR; Amin MR; France CP
Behav Pharmacol; 2005 Sep; 16(5-6):363-72. PubMed ID: 16148440
[TBL] [Abstract][Full Text] [Related]
12. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys.
McMahon LR; France CP
Exp Clin Psychopharmacol; 2003 Nov; 11(4):286-93. PubMed ID: 14599262
[TBL] [Abstract][Full Text] [Related]
16. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats.
Malone DT; Taylor DA
Behav Brain Res; 2006 Jan; 166(1):101-9. PubMed ID: 16143410
[TBL] [Abstract][Full Text] [Related]
17. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
18. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
[TBL] [Abstract][Full Text] [Related]
19. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
French ED
Neurosci Lett; 1997 May; 226(3):159-62. PubMed ID: 9175591
[TBL] [Abstract][Full Text] [Related]
20. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol.
Economidou D; Mattioli L; Ubaldi M; Lourdusamy A; Soverchia L; Hardiman G; Campolongo P; Cuomo V; Ciccocioppo R
Toxicol Appl Pharmacol; 2007 Aug; 223(1):73-85. PubMed ID: 17618662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]